HTX Ventures Annual Review and Outlook: Regulatory Clarity, Asset Tokenization, and Institutional Adoption Resonate
PANAMA CITY, Jan. 28, 2026 /PRNewswire/ -- Recently, HTX Ventures, the global…
HNL Lab Medicine Employees Select Local Charities for Annual Donation
ALLENTOWN, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine continues…
Ranch Sector Capital Management Ltd Outlines Partnership Roadmap in Annual Report, Plans to Deepen Collaboration with U.S. AgTech Companies
Denver, Colorado, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ranch Sector Capital Management…
Annual TomTom Traffic Index: U.S. Ranks Among Worlds Least Congested Countries Despite Gridlocked Cities
Los Angeles Tops Congestion List in U.S., New York Remains America’s Slowest…
imToken Releases 2025 Annual Report: Unifying Multi-Chain
SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- imToken, a leading decentralized wallet, today…
Crayola Announces First Class of Global Ambassadors Ahead of Annual Celebration of Creativity in Schools
Crayola Creativity Week Jan. 26 - Feb.1 set to engage millions of…
KuCoin Ranks Among Top Three Exchanges by Market Share Growth in TokenInsight’s 2025 Annual Report
KCS Records Counter-Cyclical Gains as KuCoin Leads the Industry in Spot Market…
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE…
BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026 10:30 ET | Source: BridgeBio Pharma, Inc. - Preliminary unaudited…
